« Back to Record
Roufosse, F., Goldman, M., & Cogan, E. (2006). Hypereosinophilic syndromes: a novel therapeutic indication for tyrosine kinase inhibitors and IL-5 antagonists. Drug Discovery Today: Therapeutic Strategies, 3(1) , 55-61.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/20649



